Clinical trial

Clinical Phenotype of Persons Vaccinated Against Sars-CoV-2 Hospitalized for COVID-19 Disease as a Basis for Optimalization of National Vaccination Strategy and Post-exposure Prophylaxis

Name

AZVCR_FNHK_9302

Description

The study is aimed at the clinical and laboratory characteristics of patients with completed vaccination against SARS-CoV-2 admitted to the hospital in the standard ward and intensive care unit due to the severe course of COVID-19.

Trial arms

Trial start

2021-01-01

Estimated PCD

2023-11-30

Trial end

2023-11-30

Status

Completed

Treatment

Vaccionation eighter started or full course

Vaccination against SARS-CoV-2 at any number of doses

Arms:

Patients COVID-19 positive admitted to the hospital

Size

3000

Primary endpoint

Patient phenotype

1.1.2021 - 30.6.2023

Eligibility criteria

Inclusion Criteria: * adult patients * COVID-19 positiveness * vaccination against SARS-CoV-2 (any number of doses) Exclusion Criteria: * N/A

Protocol

{'studyType': 'OBSERVATIONAL', 'patientRegistry': False, 'designInfo': {'observationalModel': 'COHORT', 'timePerspective': 'RETROSPECTIVE'}, 'enrollmentInfo': {'count': 3000, 'type': 'ACTUAL'}}

Updated at

2023-12-08

1 organization

1 product

4 indications

Organization

University Hospital Hradec Kralove

Product

Indication

Indication

Indication

Indication